Conclusions: Despite access to specialists, only a small fraction

Conclusions: Despite access to specialists, only a small fraction of CHB patients are being referred to and evaluated by hepatologists at this Northern California multi-specialty tertiary medical center. Patients who are not evaluated by a

hepatologist, Y27632 are non-English speakers and Asian women over the age of 50 are at greatest risk for not receiving recommended CHB care. Interventional programs targeted at high risk patient groups, increasing hepatology referrals and increasing awareness of AASLD guidelines across all provider types are likely to result in improved CHB care. Disclosures: Christopher L. Bowlus – Advisory Committees or Review Panels: Gilead Sciences, Inc; Consulting: Takeda; Grant/Research Support: Gilead Sciences, Inc, Intercept Pharmaceuticals, Bristol Meyers Squibb, Lumena; Speaking and Teaching: Gilead Sciences, Inc The following people have nothing to disclose: Cara Torruellas, Moon Chen, Brian Chan, Susan

Stewart, Julie Dang, Tina T. Fung, Duke A. LeTran Aims: Although women with HBV are identified prenatally and assiduous measures taken to prevent perinatal transmission to the infant, it is not clear that the women themselves receive appropriate care for their HBV. We sought to assess the quality of HBV care in HBsAg+ mothers after their pregnancy. Methods: 243 HBsAg+ women who had sought prenatal care at Massachusetts General Hospital from 1995 to 2013 were retrospectively identified and charts reviewed. The primary LY2157299 supplier outcome was adherence to five areas of the AASLD and American College of Obstetricians and Gynecologists guidelines: 1) Timely ALT checks, 2) Timely HBV DNA checks, 3) HAV, HIV and HCV testing, 4) HCC screening 5) Referral to a liver specialist. Results: Over a third (37%) of women were first diagnosed with HBV at their prenatal visit. 17% of women were never tested for HBeAg. 32% did not undergo timely ALT measurements. HBV DNA was never measured in 26% of patients and was untimely in 34% of patients. One third (34%) of the

women were at high risk for HCC based on AASLD criteria, yet only 33% of these high-risk women had a timely ultrasound. Nearly half (49%) had never been referred to a specialist for their HBV care. In multivariate selleck kinase inhibitor analysis, being followed by a liver specialist was an important predictor in determining whether a woman received appropriate care. Women were 3.7 times more likely to have a timely ALT and 8.1 times more likely to have a timely HBV DNA if they were referred to a liver specialist (p=0.001, <0.001). Conclusion: Our findings show remarkably inadequate care of HBV in mothers post-pregnancy. Since HBV is infection is already being identified during prenatal visits, quality improvement measures encompassing obstetricians, primary care doctors and hepatologists, are needed to ensure that women are appropriately engaged into hepatitis B care post-pregnancy. Disclosures: Ashwin N.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>